Land: Armenia
Språk: engelsk
Kilde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
carvedilol
Artesan Pharma GmbH & Co. KG
C07AG02
carvedilol
25mg
tablets
(30/3x10/) in blister
Prescription
Registered
2018-08-08
1 Version: 6299/002 CARVEDI-DENK 25 Tablet – oral use Beta blocker Active substance: carvedilol PACKAGE LEAFLET: INFORMATION FOR THE PATIENT READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Carvedi-Denk 25 is and what it is used for 2. What you need to know before you take Carvedi-Denk 25 3. How to take Carvedi-Denk 25 4. Possible side effects 5. How to store Carvedi-Denk 25 6. Contents of the pack and other information 1. WHAT CARVEDI-DENK 25 IS AND WHAT IT IS USED FOR Carvedi-Denk 25 belongs to the beta blocker group of medicinal products (medicines for treating high blood pressure or increased heart rate). Carvedi-Denk 25 is used for heart/circulatory diseases. Carvedi-Denk 25 is used for essential high blood pressure (not organically caused) chronic stable angina pectoris all degrees of stable chronic heart failure (cardiac insufficiency), of ischaemic or nonischaemic origin (dependent or not on circulation disorders). Use is accompanied by treatment with diuretics and ACE inhibitors and, if need be, digitalis (medicines acting on the heart and vascular system) Carvedi-Denk 25 may be used for essential hypertension alone or in combination with other blood pressure-lowering medicines, especially thiazide diuretics. Patients with heart failure should have been clinically stable on standard heart failure therapy (e.g. diuretics, digitalis, ACE inhibitors) for approximately 4 weeks before starting treatment with Carvedi- Denk 25. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CARVEDI-DENK Les hele dokumentet
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Carvedi-Denk 6.25 mg tablets Carvedi-Denk 25 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: carvedilol _Carvedi-Denk 6.25 mg tablets: _ Each tablet contains 6.25 mg carvedilol. _Carvedi-Denk 25 mg tablets: _ Each tablet contains 25 mg carvedilol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets Round, whitish, half-scored tablets. _ _ The tablets can be divided into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This medicinal product is a non-selective beta and alpha1 receptor antagonist. Carvedi-Denk is used in adults. _Carvedi-Denk 6.25 mg tablets: _ - Chronic heart failure: In the absence of contraindications, Carvedi-Denk 6.25 mg is indicated in all patients with stable, symptomatic, chronic heart failure of ischaemic or non-ischaemic origin of any intensity, combined with standard therapy (such as ACE inhibitors and diuretics with or without digitalis). _Carvedi-Denk 25 mg tablets: _ - Essential hypertension - Chronic stable angina pectoris - Chronic heart failure: In the absence of contraindications, Carvedi-Denk 25 mg is indicated in all patients with stable, symptomatic, chronic heart failure of ischaemic or non-ischaemic origin of any intensity, combined with standard therapy (such as ACE inhibitors and diuretics with or without digitalis). 2 _Note (on use in chronic heart failure): _ Treatment with carvedilol may be commenced only if the patient's condition has been stabilised on conventional, basic heart failure therapy, i.e. the dosage of this existing, standard therapy must have remained stable for at least four weeks prior to starting treatment with carvedilol. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Essential hypertension _ Treatment should begin with 12.5 mg carvedilol once daily on the first two days. Treatment can then be continued with 25 mg carvedilol once daily. As a rule, 25 mg carvedilol once daily is sufficient. If the effect is inad Les hele dokumentet